Eli Lilly Corp. buy Guggenheim
Start price
26.02.26
/
50%
€859.40
Target price
26.02.27
€988.24
Performance (%)
-12.17%
Price
07:32
€754.80
Summary
This prediction is currently active. The prediction for Eli Lilly Corp. disappoints with a performance of -12.17%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -4.215% | -4.215% |
| iShares Core DAX® | -1,74 % | 5,67 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its price target raised by Guggenheim from $1,161.00 to $1,168.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€656.40
14.04.25
14.04.25
€814.97
14.04.26
14.04.26
19.47%
15.04.26
15.04.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-28.93%
17.08.25
17.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25